Orchestra Biomed Holdings (NASDAQ: OBIO) reported Q4 2023 earnings per share (EPS) of -$0.37, up 15.91% year over year. Total Orchestra Biomed Holdings earnings for the quarter were -$12.82 million. In the same quarter last year, Orchestra Biomed Holdings's earnings per share (EPS) was -$0.44.
As of Q2 2024, Orchestra Biomed Holdings's earnings has grown year over year. Orchestra Biomed Holdings's earnings in the past year totalled -$49.12 million.
What was OBIO's revenue last quarter?
Orchestra Biomed Holdings (NASDAQ: OBIO) reported Q4 2023 revenue of $262.00 thousand up 76.25% year over year. In the same quarter last year, Orchestra Biomed Holdings's revenue was $1.10 million.
What was OBIO's revenue growth in the past year?
As of Q2 2024, Orchestra Biomed Holdings's revenue has grown -21.88% year over year. This is 166.51 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Orchestra Biomed Holdings's revenue in the past year totalled $2.76 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.